{"id":136248,"date":"2025-12-04T10:01:23","date_gmt":"2025-12-04T09:01:23","guid":{"rendered":"https:\/\/www.bcfi.be\/?post_type=avada_portfolio&#038;p=136248"},"modified":"2026-03-16T14:31:06","modified_gmt":"2026-03-16T13:31:06","slug":"gliflozinen-sglt2-inhibitoren-bij-type-2-diabetes","status":"publish","type":"avada_portfolio","link":"https:\/\/bcfi.be\/nl\/portfolio\/gliflozinen-sglt2-inhibitoren-bij-type-2-diabetes\/","title":{"rendered":"Gliflozinen (SGLT2-inhibitoren) bij type 2-diabetes"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-text fusion-text-1\"><p>SGLT2-inhibitoren krijgen de laatste jaren in verschillende richtlijnen een belangrijkere rol bij type 2-diabetes. Hoe vertaal je dat naar je dagelijkse praktijk?<\/p>\n<p>Aan de hand van concrete casussen \u00e9n twee korte interactieve games leer je:<\/p>\n<ul>\n<li>welke pati\u00ebnten in aanmerking komen voor gliflozinen, en bij wie je ze beter vermijdt;<\/li>\n<li>hoe je veilig gliflozinen opstart, en waar je op let bij de opvolging;<\/li>\n<li>wat de belangrijkste risico\u2019s zijn, en hoe je problemen voorkomt.<\/li>\n<\/ul>\n<p>Daarnaast krijg je een praktische tool en een pati\u00ebntenbrief om direct in je praktijk te gebruiken.<\/p>\n<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>&#9201; <b>30&#8242;<\/b><br \/>Wat elke huisarts en apotheker moet weten over het veilig gebruik van deze geneesmiddelen.<br \/><b>Arts: 0.5 CP, Officina-apotheker: 1 CP, Ziekenhuisapotheker: 1 CP<\/b><br \/>&#9202; december 2025<\/p>\n","protected":false},"author":13,"featured_media":136242,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","format":"standard","meta":{"footnotes":""},"portfolio_category":[70,69],"portfolio_skills":[139,140,142],"portfolio_tags":[20350,20351,20352],"class_list":["post-136248","avada_portfolio","type-avada_portfolio","status-publish","format-standard","has-post-thumbnail","hentry","portfolio_category-voor-artsen","portfolio_category-voor-apothekers","portfolio_skills-arts-0-5-cp","portfolio_skills-officina-apotheker-1-cp","portfolio_skills-ziekenhuisapotheker-1-cp","portfolio_tags-antidiabetica","portfolio_tags-sglt2-inhibitor","portfolio_tags-gliflozine"],"_links":{"self":[{"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/avada_portfolio\/136248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/avada_portfolio"}],"about":[{"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/types\/avada_portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/comments?post=136248"}],"version-history":[{"count":4,"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/avada_portfolio\/136248\/revisions"}],"predecessor-version":[{"id":180100,"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/avada_portfolio\/136248\/revisions\/180100"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/media\/136242"}],"wp:attachment":[{"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/media?parent=136248"}],"wp:term":[{"taxonomy":"portfolio_category","embeddable":true,"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/portfolio_category?post=136248"},{"taxonomy":"portfolio_skills","embeddable":true,"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/portfolio_skills?post=136248"},{"taxonomy":"portfolio_tags","embeddable":true,"href":"https:\/\/bcfi.be\/nl\/wp-json\/wp\/v2\/portfolio_tags?post=136248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}